{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:58:14Z","timestamp":1786985894278,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013647","name":"College of Natural Sciences, University of Massachusetts Amherst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","award":["MAS00556"],"award-info":[{"award-number":["MAS00556"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cdn.nutrition.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Developments in Nutrition"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cdnut.2023.101972","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T20:58:37Z","timestamp":1689627517000},"page":"101972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cannabidiol and Intestinal Motility: a Systematic Review"],"prefix":"10.1016","volume":"7","author":[{"given":"Galaxie","family":"Story","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie-Ellen","family":"Briere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Julian","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-7470","authenticated-orcid":false,"given":"David A.","family":"Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cdnut.2023.101972_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","article-title":"Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history","volume":"227","author":"Bonini","year":"2018","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.cdnut.2023.101972_bib2","series-title":"National Library of Medicine","year":"2021"},{"key":"10.1016\/j.cdnut.2023.101972_bib3","series-title":"National Library of Medicine PubChem","year":"2021"},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Braz. J. Psychiatry"},{"issue":"17","key":"10.1016\/j.cdnut.2023.101972_bib5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","article-title":"Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis","volume":"78","author":"Lattanzi","year":"2018","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/can.2021.0041","article-title":"Therapeutic potential of cannabidiol, cannabidiolic acid, and cannabidiolic acid methyl ester as treatments for nausea and vomiting","volume":"6","author":"Rock","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.cdnut.2023.101972_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cdnut.2023.101972_bib9","series-title":"14% of Americans say they use CBD products [Internet]","author":"Brenan","year":"2019"},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.cdnut.2023.101972_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jhsa.2022.03.002","article-title":"A\u00a0randomized controlled trial of topical cannabidiol for the treatment of thumb basal joint arthritis","volume":"47","author":"Heineman","year":"2022","journal-title":"J.\u00a0Hand Surg. Am."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s42238-022-00154-9","article-title":"Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study","volume":"4","author":"Frane","year":"2022","journal-title":"J.\u00a0Cannabis Res."},{"issue":"5","key":"10.1016\/j.cdnut.2023.101972_bib13","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1053\/j.gastro.2011.07.036","article-title":"Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome","volume":"141","author":"Wong","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2982.2011.01874.x","article-title":"Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea","volume":"24","author":"Wong","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.cdnut.2023.101972_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuroimage.2019.05.012","article-title":"Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: a report of a potential biomarker of intoxication","volume":"197","author":"Gilman","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.cdnut.2023.101972_bib16","series-title":"Drug Scheduling","year":"2021"},{"key":"10.1016\/j.cdnut.2023.101972_bib17","series-title":"Cannabidiol (CBD) Oil: Global Markets","year":"2020"},{"key":"10.1016\/j.cdnut.2023.101972_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fphar.2020.00063","article-title":"Cannabidiol drugs clinical trial outcomes and adverse effects","volume":"11","author":"Pauli","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.cdnut.2023.101972_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","article-title":"Cannabidiol adverse effects and toxicity","volume":"17","author":"Huestis","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib20","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcph.1412","article-title":"A\u00a0phase 1, open-label, parallel-group, single-dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment","volume":"59","author":"Taylor","year":"2019","journal-title":"J.\u00a0Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"issue":"7","key":"10.1016\/j.cdnut.2023.101972_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib24","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","article-title":"Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy","volume":"1","author":"Ujv\u00e1ry","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.cdnut.2023.101972_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A\u00a0systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.cdnut.2023.101972_bib27","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1612177114","article-title":"Endocannabinoid system acts as a regulator of immune homeostasis in the gut","volume":"114","author":"Acharya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.cdnut.2023.101972_bib29","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/acer.14256","article-title":"Cannabinoids and the microbiota\u2013gut\u2013brain axis: emerging effects of cannabidiol and potential applications to alcohol use disorders","volume":"44","author":"Karoly","year":"2020","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain-gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cdnut.2023.101972_bib33","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 cannabinoid receptors as a therapeutic target-what does the future hold?","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"42","key":"10.1016\/j.cdnut.2023.101972_bib35","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1073\/pnas.1514996112","article-title":"A\u00a0runner\u2019s high depends on cannabinoid receptors in mice","volume":"112","author":"Fuss","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cdnut.2023.101972_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2010.00132","article-title":"Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice","volume":"1","author":"Kimball","year":"2010","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.cdnut.2023.101972_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000339072","article-title":"The gastrointestinal pharmacology of cannabinoids: focus on motility","volume":"90","author":"Abalo","year":"2012","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MCG.0b013e3181dd1573","article-title":"Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study","volume":"45","author":"Park","year":"2011","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"47","key":"10.1016\/j.cdnut.2023.101972_bib40","doi-asserted-by":"crossref","first-page":"17693","DOI":"10.3748\/wjg.v20.i47.17693","article-title":"Genetic polymorphism in pathogenesis of irritable bowel syndrome","volume":"20","author":"Cheung","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/onc.2010.502","article-title":"The putative cannabinoid receptor GPR55 promotes cancer cell proliferation","volume":"30","author":"Hu","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib43","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/JME-16-0253","article-title":"GPR55: a new promising target for metabolism?","volume":"58","author":"Tudur\u00ed","year":"2017","journal-title":"J.\u00a0Mol. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.cdnut.2023.101972_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-3084(00)00190-0","article-title":"The fatty acid amide hydrolase (FAAH)","volume":"108","author":"Ueda","year":"2000","journal-title":"Chem. Phys. Lipids"},{"issue":"5","key":"10.1016\/j.cdnut.2023.101972_bib45","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1476-5381.2011.01644.x","article-title":"Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice","volume":"165","author":"Bashashati","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","volume":"54","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.cdnut.2023.101972_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2982.2008.01175.x","article-title":"The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome","volume":"20","author":"Storr","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib49","doi-asserted-by":"crossref","first-page":"G655","DOI":"10.1152\/ajpgi.00294.2015","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Review article: endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.cdnut.2023.101972_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/nmo.12617","article-title":"Serotonin and colonic motility","volume":"27","author":"Kendig","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.930255","article-title":"Neurohumoral control of gastrointestinal motility","volume":"52","author":"Hansen","year":"2003","journal-title":"Physiol. Res."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00535-012-0726-5","article-title":"Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases","volume":"48","author":"Grover","year":"2013","journal-title":"J.\u00a0Gastroenterol."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib54","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/ijms22041863","article-title":"Cannabidiol as a potential treatment for anxiety and mood disorders: molecular targets and epigenetic insights from preclinical research","volume":"22","author":"Melas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cdnut.2023.101972_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.cdnut.2023.101972_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib57","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.cdnut.2023.101972_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1016\/j.cdnut.2023.101972_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cdnut.2023.101972_bib60","series-title":"Human Anatomy and Physiology","first-page":"887","article-title":"The digestive system","author":"Marieb","year":"2013"},{"issue":"9573","key":"10.1016\/j.cdnut.2023.101972_bib61","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(07)60726-0","article-title":"Clinical update: irritable bowel syndrome","volume":"369","author":"Spiller","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000494412","article-title":"Irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission: association with residual colonic inflammation","volume":"99","author":"Ishihara","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.cdnut.2023.101972_bib63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JIR.S174982","article-title":"The role of inflammation in irritable bowel syndrome (IBS)","volume":"11","author":"Ng","year":"2018","journal-title":"J.\u00a0Inflamm. Res."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gtc.2005.02.007","article-title":"Is irritable bowel syndrome a low-grade inflammatory bowel disease?","volume":"34","author":"Bercik","year":"2005","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"12","key":"10.1016\/j.cdnut.2023.101972_bib65","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/modpathol.3800704","article-title":"Histopathological alterations in irritable bowel syndrome","volume":"19","author":"Kirsch","year":"2006","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10151-020-02168-y","article-title":"Abnormal gut motility in inflammatory bowel disease: an update","volume":"24","author":"Bassotti","year":"2020","journal-title":"Tech. Coloproctol."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","article-title":"Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis","volume":"264","author":"Fond","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1476-5381.1973.tb08534.x","article-title":"The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice","volume":"49","author":"Chesher","year":"1973","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(25)23416-4","article-title":"Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents","volume":"249","author":"Shook","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1974.tb09240.x","article-title":"Interaction of delta9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice","volume":"26","author":"Anderson","year":"1974","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib72","first-page":"486","article-title":"Industrial hemp decreases intestinal motility stronger than Indian hemp in mice","volume":"17","author":"Sabo","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cdnut.2023.101972_bib73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphar.2016.00341","article-title":"An orally active cannabis extract with high content in cannabidiol attenuates chemically induced intestinal inflammation and hypermotility in the mouse","volume":"7","author":"Pagano","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cdnut.2023.101972_bib74","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjp.2008.177","article-title":"Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice","volume":"154","author":"Capasso","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib75","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2982.2008.01114.x","article-title":"Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase","volume":"20","author":"de Filippis","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"issue":"100","key":"10.1016\/j.cdnut.2023.101972_bib76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","article-title":"A\u00a0role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice","volume":"71","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.cdnut.2023.101972_bib77","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2982.2011.01742.x","article-title":"A\u00a0novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents","volume":"23","author":"Lin","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13756","article-title":"Effects of O-1602 and CBD on TNBS-induced colonic disturbances","volume":"32","author":"Wei","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib79","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/biomedicines10081793","article-title":"Differential effects of D9 tetrahydrocannabinol (THC)- and cannabidiol (CBD)-based cannabinoid treatments on macrophage immune function in vitro and on gastrointestinal inflammation in a murine model","volume":"10","author":"Yekhtin","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib80","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.neuropharm.2005.01.023","article-title":"Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors","volume":"48","author":"Fride","year":"2005","journal-title":"Neuropharmacology"},{"issue":"3\u20134","key":"10.1016\/j.cdnut.2023.101972_bib81","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000336871","article-title":"Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice","volume":"89","author":"Schicho","year":"2012","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.cdnut.2023.101972_bib82","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ecco-jcc\/jjaa253","article-title":"Cannabinoid receptor activation on haematopoietic cells and enterocytes protects against colitis","volume":"15","author":"Becker","year":"2021","journal-title":"J.\u00a0Crohns Colitis"},{"key":"10.1016\/j.cdnut.2023.101972_bib83","doi-asserted-by":"crossref","first-page":"585096","DOI":"10.3389\/fphar.2020.585096","article-title":"Fish oil, cannabidiol and the gut microbiota: an investigation in a murine model of colitis","volume":"11","author":"Silvestri","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A\u00a0randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.cdnut.2023.101972_bib85","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for Crohn\u2019s disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib86","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","article-title":"Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn\u2019s disease, a randomised controlled trial","volume":"15","author":"Naftali","year":"2021","journal-title":"J.\u00a0Crohns Colitis"},{"issue":"4","key":"10.1016\/j.cdnut.2023.101972_bib87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/can.2020.0087","article-title":"Effects of cannabidiol chewing gum on perceived pain and well-being of irritable bowel syndrome patients: a placebo-controlled crossover exploratory intervention study with symptom-driven dosing","volume":"7","author":"van Orten-Luiten","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"issue":"9","key":"10.1016\/j.cdnut.2023.101972_bib88","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s12272-011-0913-6","article-title":"The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus","volume":"34","author":"Cluny","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib89","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrgastro.2012.168","article-title":"Regulation of gastrointestinal motility\u2014insights from smooth muscle biology","volume":"9","author":"Sanders","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.cdnut.2023.101972_bib90","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","article-title":"The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis","volume":"160","author":"Jamontt","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib91","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/ijms22020926","article-title":"Functions of muscarinic receptor subtypes in gastrointestinal smooth muscle: a review of studies with receptor-knockout mice","volume":"22","author":"Tanahashi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cdnut.2023.101972_bib92","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cdnut.2023.101972_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-food-032519-051834","article-title":"Enhancing efficacy, performance, and reliability of cannabis edibles: insights from lipid bioavailability studies","volume":"11","author":"McClements","year":"2020","journal-title":"Annu. Rev. Food Sci. Technol."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib94","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.cdnut.2023.101972_bib95","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.xphs.2017.12.020","article-title":"PTL401, a new formulation based on pro-nano dispersion technology, improves oral cannabinoids bioavailability in healthy volunteers","volume":"107","author":"Atsmon","year":"2018","journal-title":"J.\u00a0Pharm. Sci."},{"issue":"8","key":"10.1016\/j.cdnut.2023.101972_bib96","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.16093","article-title":"Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy","volume":"60","author":"Birnbaum","year":"2019","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.cdnut.2023.101972_bib97","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/epi.16419","article-title":"A\u00a0phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects","volume":"61","author":"Crockett","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.cdnut.2023.101972_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.cdnut.2023.101972_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1691428","article-title":"Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer","volume":"2018","author":"Pellati","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"11","key":"10.1016\/j.cdnut.2023.101972_bib100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","article-title":"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis","volume":"87","author":"Borrelli","year":"2009","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.cdnut.2023.101972_bib101","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3389\/fmicb.2016.01934","article-title":"The neuro-endocrinological role of microbial glutamate and GABA signaling","volume":"7","author":"Mazzoli","year":"2016","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.cdnut.2023.101972_bib102","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/19390211.2020.1761506","article-title":"Potential probiotic or trigger of gut inflammation - the Janus-faced nature of cannabidiol-rich cannabis extract","volume":"17","author":"Skinner","year":"2020","journal-title":"J.\u00a0Diet. Suppl."},{"key":"10.1016\/j.cdnut.2023.101972_bib103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbi.2019.07.028","article-title":"Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome","volume":"82","author":"Al-Ghezi","year":"2019","journal-title":"Brain Behav. Immun."}],"container-title":["Current Developments in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475299123247952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475299123247952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:44:35Z","timestamp":1762865075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475299123247952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2475299123247952"],"URL":"https:\/\/doi.org\/10.1016\/j.cdnut.2023.101972","relation":{},"ISSN":["2475-2991"],"issn-type":[{"value":"2475-2991","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and Intestinal Motility: a Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Current Developments in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cdnut.2023.101972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"101972"}}